what would you tell week-1 you about glucagon
what would you tell week-1 you about glucagon, and I want the answer with the reasoning attached rather than just the conclusion. Sent a vial to Medutest out of curiosity. Result was 99.2% against a claimed 98.5%, which is the first independent number I had seen for this compound anywhere. The thing that surprised me…
Trial names corrected in the title. The phase 3 programme and the phase 2 readout are not the same thing.
phase 2 data only, and people quote it like it is a label
Increases in heart rate have been reported across this receptor class. The magnitude and clinical significance are exactly what phase 3 is powered to establish.
Kept a log specifically because there is so little published. It is one person and it is not data.
The phase 2 readout ran to 48 weeks in a few hundred participants with a slow escalation. Both the size and the duration matter when people quote the headline number.
Stopped at a low step because there was no reason to go further and no data to tell me what further would do.